PAG
TEVA icon

Private Advisor Group’s Teva Pharmaceuticals TEVA Stock Holding History

Private Advisor Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,200
Closed -$2K – 1071
2014
Q4 		$2K Buy
+1,200
New +$66.9K ﹤0.01% 997

Other funds holding TEVA

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
FAF
Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Private Advisor Group's TEVA Position: Q2 2026 in Review

Private Advisor Group reduced its Teva Pharmaceuticals (TEVA) stake by 16% in Q2 2026, selling an estimated $116K and leaving 18,399 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #1638.

Private Advisor Group first reported a position in TEVA in Q1 2014 and has held it in 49 quarters since. The position peaked at $721K in Q3 2018. 232 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Private Advisor Group held 18,399 shares of Teva Pharmaceuticals worth $623K as of Q2 2026.
  • Private Advisor Group sold 3,489 Teva Pharmaceuticals shares in Q2 2026, an estimated $116K.
  • Teva Pharmaceuticals made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1638 holding.
  • Private Advisor Group first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 49 quarters since.
  • Private Advisor Group's Teva Pharmaceuticals position peaked at $721K in Q3 2018.
  • 232 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.